Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? We cover all that and more this week on “The Readout LOUD,” STAT’s …
Read MoreTag: The Readout LOUD
Listen: George Scangos’ retirement, annual Covid vaccines, an Alzheimer’s drug rejection
Who needs an annual Covid jab? Why did the FDA reject an Alzheimer’s treatment? And what’s in store for one of biotech’s most highly respected executives now that he’s stepping …
Read More
Listen: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms
Can Covid denialism get you elected? How is the music business like biotech investing? And what’s at stake for science in the midterms? We cover all that and more this …
Read More
BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
What happens when approved drugs turn out not to work? Is it OK to make SARS-CoV-2 hybrids? And are British tabloids reliable sources of science news? We cover all that …
Read More
Listen: Biden’s Covid declaration, twilight of the SPAC, & genome editing 2.0
When is a pandemic “over?” Did biotech over-SPAC? And what can’t be CRISPR’d? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Heidi Tworek, …
Read More
Fauci’s non-retirement, grading biotech VCs, & a bellwether IPO
Are we getting Covid-19 boosters wrong? Which venture capitalists are missing their marks? And what’s Anthony Fauci’s legacy? We cover all that and more this week on “The Readout LOUD,” …
Read More
Listen: CRISPR for the heart, biotech’s recovery, & what it means to be a ‘hot girl’
Can CRISPR edit out a heart attack? What happens on #GutTok? And is health care recession-proof? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech …
Read More
Listen: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
How do you stop a Covid surge? Why are clinical trials so white? And what are the limits of HIPAA? We cover all that and more this week on “The …
Read More
Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer’s setback
Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can anything stop the amyloid hypothesis? We cover all that and more this week on “The …
Read More